PTHS
Pelthos Therapeutics Inc.Company with tickers: PTHS
CIK
1919246
CUSIP
171126204
Shares Outstanding
3,475,645
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $10,906,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $186,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-13,088,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-10,238,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-3.09 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-3.09 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |